Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #72026-05-1913%External coverage
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-42025-12-3043%External coverage
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study2025-07-2843%External coverage
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry2025-07-2313%External coverage